Traumatic Brain Injury Treatment
Most TBI patients are told their MRI looks fine and sent home with a prescription for rest. The injury doesn’t end there. When standard neurology stops looking, metabolic damage, chronic neuroinflammation, and disrupted neural connectivity continue to drive symptoms for months or years. We pick up where that evaluation left off.
Why Most TBI Patients Are Still Struggling
A normal CT scan or structural MRI does not mean a normal brain. These imaging tools are designed to detect fractures, bleeds, and large structural lesions. They were never built to identify the diffuse axonal injury, mitochondrial dysfunction, or low-grade neuroinflammation that drives most persistent TBI symptoms. A 2015 study published in The Journal of Neurotrauma (Eierud et al., 2014) found that up to 30% of patients with mild TBI and normal conventional imaging still showed abnormalities on advanced neuroimaging sequences.
The result is a diagnostic gap. Patients present with headaches, brain fog, fatigue, irritability, sleep disruption, and worsening mood. Their scans come back clean. They’re told to give it time, try physical therapy, or see a psychiatrist. Some are prescribed antidepressants or stimulants to mask individual symptoms without addressing the underlying injury.
This is not a failure of effort by the treating physicians. It is a failure of the standard workup. The tools most neurologists rely on were designed for a different set of questions. When you ask the wrong question, you get the wrong answer—and the patient stays stuck.
Chronic TBI also carries a measurable metabolic cost. Research from the Department of Defense TBI Biomarker Study (Gill et al., 2018, published in JAMA Neurology) demonstrated persistently elevated levels of tau, GFAP, and other neuroinflammatory markers in patients with mild TBI months after injury. These markers point to ongoing cellular damage that no amount of rest will resolve on its own.
What Advanced Diagnostics Reveal
We begin every TBI evaluation with diagnostic tools that go beyond structure and into function. PET scanning maps glucose metabolism across every region of the brain. In TBI patients, PET frequently reveals areas of hypometabolism—regions that are alive but operating well below capacity. These metabolic cold spots correlate directly with the cognitive and emotional symptoms patients describe.
Functional MRI adds a second layer by measuring connectivity between neural networks. TBI often disrupts the default mode network, the salience network, and frontoparietal circuits responsible for attention and executive function. A study by Mayer et al. (2011, published in Human Brain Mapping) showed that functional connectivity disruptions in mild TBI patients predicted symptom severity more accurately than any structural finding.
Neurogenomic lab panels complete the picture. We measure inflammatory cytokines, markers of oxidative stress, neurotransmitter metabolites, mitochondrial function markers, and genetic variants that affect how a given patient metabolizes nutrients, clears toxins, and repairs myelin. These labs tell us not just what is broken, but why recovery has stalled for a particular individual.
The combination of metabolic imaging, connectivity mapping, and molecular profiling produces a level of diagnostic detail that no single test can provide alone. Learn more about our imaging approach on our brain imaging page.
Our Treatment Protocol for TBI
Once diagnostic testing identifies the specific injury pattern, we assemble a treatment protocol from therapies that target mitochondrial recovery, neuroinflammation, and cellular repair. No two TBI cases are identical, and no two protocols should be either.
NAD+ intravenous therapy is a foundational component. Nicotinamide adenine dinucleotide is the central coenzyme in mitochondrial energy production. After TBI, mitochondria in injured neurons become dysfunctional, producing less ATP and generating more reactive oxygen species. IV NAD+ restores the substrate these organelles need to resume normal energy output. A 2017 study by Ying and colleagues (published in Frontiers in Bioscience) demonstrated that NAD+ repletion protected neurons from secondary injury cascades in preclinical TBI models.
Exosome therapy delivers extracellular vesicles loaded with anti-inflammatory cytokines, growth factors, and microRNAs directly into the system. These vesicles cross the blood-brain barrier and modulate the local immune response at injury sites. Zhang et al. (2015, published in Neuroscience Letters) showed that mesenchymal stem cell-derived exosomes improved functional recovery and reduced neuroinflammation in TBI animal models.
Mesenchymal stem cell therapy goes further by introducing cells capable of paracrine signaling, immunomodulation, and direct support of tissue repair. These cells home to areas of inflammation and begin releasing trophic factors that promote angiogenesis, reduce scarring, and support axonal regrowth. Cox et al. (2017, published in Stem Cells) reported improved outcomes and reduced neuroinflammatory markers in TBI patients treated with autologous bone marrow-derived cells.
Ketamine infusion therapy addresses the psychiatric and pain dimensions of TBI that frequently resist standard pharmacotherapy. Ketamine acts on NMDA receptors and promotes BDNF expression, supporting synaptic plasticity in circuits that TBI often damages. For patients with treatment-resistant depression, chronic pain, or PTSD overlapping with their brain injury, ketamine can produce rapid and measurable improvements in mood, sleep, and pain processing.
These therapies are delivered together during our Intensive Brain Health Program, a three-to-five-day immersive protocol that combines diagnostics, physician review, and a full course of treatment in a single visit.
Who We See
TBI affects people from every background and at every stage of life. These are the populations we treat most often.
Athletes & Former Athletes
Contact sport athletes accumulate subconcussive hits over years. Football, hockey, soccer, boxing, and MMA athletes frequently present with cognitive decline, mood instability, and sleep disruption years after their playing careers have ended. We evaluate the cumulative metabolic toll of repetitive head impacts and build protocols around the specific regions affected.
Motor Vehicle Accidents
Car and motorcycle accidents produce sudden acceleration- deceleration forces that damage axons diffusely throughout the brain. Many patients are cleared by an ER CT scan and told to follow up with their primary care doctor. Months later, they’re still dealing with headaches, cognitive slowing, and fatigue that nobody can explain. Advanced imaging frequently reveals the damage that the initial workup missed.
Military & Veterans
Blast exposure produces a distinct pattern of brain injury that differs from blunt-impact TBI. The pressure wave from an IED or mortar round damages small blood vessels and white matter tracts in ways that conventional imaging often cannot detect. Veterans frequently carry overlapping TBI and PTSD, which complicates diagnosis and limits the effectiveness of standard VA treatment protocols. Our diagnostic approach separates these overlapping conditions so each can be treated directly.
Falls & Workplace Injuries
Falls are the leading cause of TBI across all age groups, according to the CDC. Construction workers, warehouse employees, and older adults who sustain falls with head impact often develop persistent symptoms that are attributed to aging, stress, or depression rather than to the injury itself. A proper metabolic and functional workup frequently identifies treatable pathology that has been overlooked.
Related Treatments
NAD+ IV Therapy
Restore mitochondrial energy production in neurons damaged by trauma. NAD+ is the primary substrate for ATP synthesis and a key regulator of DNA repair enzymes activated after brain injury.
Exosome Therapy
Extracellular vesicles that cross the blood-brain barrier and deliver anti-inflammatory signals, growth factors, and regulatory microRNAs to injured neural tissue.
Stem Cell Therapy
Mesenchymal stem cells modulate the post-injury immune response, reduce glial scarring, and release neurotrophic factors that support axonal repair and new vessel formation.
Frequently Asked Questions
What makes The Neurogenesis Project different for TBI patients?+
What diagnostic tools do you use for TBI evaluation?+
What treatments are available for TBI at your clinic?+
How long does TBI treatment take?+
Does insurance cover TBI treatment at your clinic?+
Who is a good candidate for this program?+
Your Brain Injury Deserves a Real Evaluation
If you’ve been told your scans are normal but you still don’t feel right, that gap between what the tests show and what you experience is exactly where we work. Dr. Orr and the team at The Neurogenesis Project are accepting new TBI patients in St. Marys, Georgia.